Showing results (41-50 of 48) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Mabs|January 21, 2014
Assessment of chemical modifications of sites in the CDRs of recombinant antibodies: Susceptibility vs. functionality of critical quality attributesMarkus Haberger, Katrin Bomans, Katharina Diepold, et al.Mabs|October 12, 2023
Delivery of the Brainshuttle™ amyloid-beta antibody fusion trontinemab to non-human primate brain and projected efficacious dose regimens in humansHans Peter Grimm, Vanessa Schumacher, Martin Schäfer, et al.Nature Communications|February 14, 2018
A human endothelial cell-based recycling assay for screening of FcRn targeted moleculesAlgirdas Grevys, Jeannette Nilsen, Kine M K Sand, et al.Mabs|March 18, 2016
XGFR*, a novel affinity-matured bispecific antibody targeting IGF-1R and EGFR with combined signaling inhibition and enhanced immune activation for the treatment of pancreatic cancerJuergen M Schanzer, Katharina Wartha, Ekkehard Moessner, et al.Structure (London, England : 1993)|August 15, 2024
Engineering of pH-dependent antigen binding properties for toxin-targeting IgG1 antibodies using light-chain shufflingTulika Tulika, Fulgencio Ruso-Julve, Shirin Ahmadi, et al.Science Translational Medicine|October 15, 2020
An engineered human albumin enhances half-life and transmucosal delivery when fused to protein-based biologicsMalin Bern, Jeannette Nilsen, Mattia Ferrarese, et al.Nature Communications|March 7, 2024
Human IgG Fc-engineering for enhanced plasma half-life, mucosal distribution and killing of cancer cells and bacteriaStian Foss, Siri A Sakya, Leire Aguinagalde, et al.Mabs|July 8, 2025
Impact of antibody Fc engineering on translational pharmacology, and safety: insights from industry case studiesFrank R Brennan, J Ryan Polli, Jean Sathish, et al.Pageof 5